HistoSonics Edison System Recognized With BioTech Breakthrough Award For “MedTech Innovation Of The Year”
08 nov. 2023 08h02 HE
|
BioTech Breakthrough
LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
Cell Culture Market Size is projected to reach USD 67.34 Billion by 2030, growing at a CAGR of 12.86%: Straits Research
26 juil. 2022 13h10 HE
|
Straits Research
New York, United States, July 26, 2022 (GLOBE NEWSWIRE) -- Cell culture is defined as the process of removing cells from a plant or animal source and then growing them under controlled conditions...
Frozen Tissues Samples Market Size Worth $105.04 Mn, Globally, by 2028 at 13.1% CAGR - Exclusive Report by The Insight Partners
29 mars 2022 06h00 HE
|
The Insight Partners
New York, March 29, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Frozen Tissues Samples Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
25 févr. 2021 08h30 HE
|
RenovaCare, Inc.
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
22 déc. 2020 08h00 HE
|
RenovaCare, Inc.
ROSELAND, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones
19 nov. 2020 08h15 HE
|
RenovaCare, Inc.
ROSELAND, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020
22 oct. 2020 16h35 HE
|
RenovaCare, Inc.
ROSELAND, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
RenovaCare to Present at BioNJ/JP Morgan/J&J BioPartnering Conference
15 sept. 2020 08h30 HE
|
RenovaCare, Inc.
ROSELAND, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility
11 août 2020 08h30 HE
|
RenovaCare, Inc.
ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
RenovaCare Launches R&D Innovation Center (Berlin) for Organ & Tissue Regeneration
01 juil. 2020 08h30 HE
|
RenovaCare, Inc.
ROSELAND, N.J., July 01, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced the official launch of its new RenovaCare R&D Innovation Center in...